Rare DiseasesSickle cell tablet lifts blood counts but pain crises barely move
In the Lancet-published RISE UP trial, mitapivat raised haemoglobin in 41% of people with sickle cell disease against 3% on placebo, but pain crises didn't fall significantly.
22 October 2026